136 related articles for article (PubMed ID: 35039863)
1. Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018.
Spradling PR; Xing J; Zhong Y; Rupp LB; Moorman AC; Lu M; Teshale EH; Schmidt MA; Daida YG; Boscarino JA; Gordon SC
J Infect Dis; 2022 Sep; 226(5):896-900. PubMed ID: 35039863
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma and other liver disease among Greenlanders chronically infected with hepatitis B virus: a population-based study.
Børresen ML; Koch A; Biggar RJ; Andersson M; Wohlfahrt J; Ladefoged K; Melbye M
J Natl Cancer Inst; 2011 Nov; 103(22):1676-85. PubMed ID: 22021665
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
4. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
6. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
[TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis B and hepatocellular carcinoma.
McClune AC; Tong MJ
Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?
Sonneveld MJ; Brouwer WP; de Man RA
J Hepatol; 2020 Sep; 73(3):728-729. PubMed ID: 32423630
[No Abstract] [Full Text] [Related]
9. Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".
Chan HL; Wong VW; Yip TC; Wong GL
J Hepatol; 2020 Sep; 73(3):729-730. PubMed ID: 32423634
[No Abstract] [Full Text] [Related]
10. Hepatitis B virus-induced hepatocarcinogenesis: A virological and oncological perspective.
Arslan F; Franci G; Maria Nastri B; Pagliano P
J Viral Hepat; 2021 Aug; 28(8):1104-1109. PubMed ID: 34003561
[TBL] [Abstract][Full Text] [Related]
11. [Screening and surveillance for hepatocellular carcinoma in patients with chronic hepatitis B virus infection].
Expert Group for Project of Hepatocellular Carcinoma Screening and Surveillance, Chinese Foundation for Hepatitis Prevention and Control
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):932-941. PubMed ID: 34814387
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
13. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
[TBL] [Abstract][Full Text] [Related]
14. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance.
Mak LY; Wong DK; Pollicino T; Raimondo G; Hollinger FB; Yuen MF
J Hepatol; 2020 Oct; 73(4):952-964. PubMed ID: 32504662
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
Ji J; Sundquist K; Sundquist J
J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden.
Sundquist K; Sundquist J; Ji J
J Med Virol; 2014 Jan; 86(1):18-22. PubMed ID: 24038002
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
El-Mowafy M; Elgaml A; El-Mesery M; Elegezy M
J Med Virol; 2017 Sep; 89(9):1559-1566. PubMed ID: 28390175
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
19. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
20. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
Tseng TC; Liu CJ; Chang CT; Su TH; Yang WT; Tsai CH; Chen CL; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
J Hepatol; 2020 Jun; 72(6):1105-1111. PubMed ID: 32006586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
